Old Web
English
Sign In
Acemap
>
authorDetail
>
Eric J. Bonventre
Eric J. Bonventre
Rifamycin
Rifamycins
Microbiology
Quinolone
Staphylococcus aureus
3
Papers
125
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci
2008
Antimicrobial Agents and Chemotherapy
Gregory T. Robertson
Eric J. Bonventre
Timothy B. Doyle
Qun Du
Leonard R. Duncan
Timothy W. Morris
Eric D. Roche
Dalai Yan
A. Simon Lynch
Show All
Source
Cite
Save
Citations (42)
In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.
2008
Antimicrobial Agents and Chemotherapy
Gregory T. Robertson
Eric J. Bonventre
Timothy B. Doyle
Qun Du
Leonard R. Duncan
Timothy W. Morris
Eric D. Roche
Dalai Yan
A. Simon Lynch
Show All
Source
Cite
Save
Citations (51)
New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases
2007
Bioorganic & Medicinal Chemistry Letters
Keith D. Combrink
Daniel Denton
Susan Harran
Zhenkun Ma
Katrina Chapo
Dalai Yan
Eric J. Bonventre
Eric D. Roche
Timothy B. Doyle
Gregory T. Robertson
Anthony Simon Lynch
Show All
Source
Cite
Save
Citations (32)
1